Today we reported that Biotech firm VolitionRx (NYSEMKT:VNRX) is to collaborate with Surrey University’s cancer research institute in a retrospective study of 550 blood samples.
The study will measure how accurately VolitionRx’s NuQ blood tests can detect the early stages of prostate cancer.
Meanwhile, alternative fuel producer MagneGas (NASDAQ:MNGA) saw demand for its natural gas substitute ‘rocket’ after the group’s joint venture partner Suwannee was hired by a lead sub-contractor on a major NASA project for the Kennedy Space Center.
The two year project is part of a US$100mln plan to modify the vehicle assembly building for the space launch.
Good news for Hummingbird Resources (LON:HUM) as it reported promising potential for the Gonka deposit five kilometres from the planned Yanfolia gold project in Mali.
Investors will be buoyed by the potential of the deposit as it adds another 169,000 ounces of the precious metal to the mine life.
Staying with mining, Minerals explorer SolGold (LON:SOLG) released a batch of results from its recently completed programme at the Cascabel copper gold project in Ecuador.
Four drill holes had encountered mineralisation, one of which pointed to higher grades within an as yet untested core area.
In the world of oil, Northcote Energy (LON:NCT) now holds 38mln share warrants in MX Oil (LON:MXO), after it announced a deal to sell the Aje Field offshore Nigeria for US$18mln. In the interim it would raise £560,000 of new capital.
Internet top level domains company Minds + Machines (LON:MMX) finished 2015 with a flourish, enjoying significant growth in billings.
The company also reported it was still in the running for a number of yet-to-be assigned top level domains.
“We're making the transition from acquiring assets and beginning to monetise them, through forging the right commercial relationships,” chief executive Antony Van Couvering told Proactive Investors.
Share price stood at 7.50p, up 1.69%, at close today.